Early research (Phase 1)Ended earlyNCT00595829What this trial is testingXL019 in Adults With Polycythemia VeraWho this might be right forPolycythemia Vera Exelixis 3
Testing effectiveness (Phase 2)UnknownNCT00146913What this trial is testingAFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One YearWho this might be right forChronic Myeloid Leukemia Hospices Civils de Lyon 30
Not applicableLooking for participantsNCT07512882What this trial is testingCohort of Patients With Chronic Myelomonocytic LeukemiaWho this might be right forLeukemiaMyelomonocytic Leukemia, Chronic Gustave Roussy, Cancer Campus, Grand Paris 5,000
Testing effectiveness (Phase 2)Study completedNCT02472691What this trial is testingAzacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCTWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic Heinrich-Heine University, Duesseldorf 50
Early research (Phase 1)Study completedNCT00103701What this trial is testingBMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Myeloid, Chronic-phaseLeukemia, Lymphoblastic, Acute, Philadelphia-positive Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT00356928What this trial is testingCyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic MalignanciesWho this might be right forLeukemiaMyelodysplastic Syndromes Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Testing effectiveness (Phase 2)Study completedNCT01981850What this trial is testingRO7490677 In Participants With MyelofibrosisWho this might be right forPrimary MyelofibrosisPolycythemia VeraPost-Essential Thrombocythemia Myelofibrosis Hoffmann-La Roche 125
Early research (Phase 1)Study completedNCT00003082What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Arizona 27
Not applicableStudy completedNCT00014482What this trial is testingMusic Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell TransplantationWho this might be right forAnxiety DisorderChronic Myeloproliferative DisordersDepression+4 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00320190What this trial is testingStudy of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to ImatinibWho this might be right forLeukemia, Myeloid, Chronic Bristol-Myers Squibb 52
Testing effectiveness (Phase 2)Ended earlyNCT02029417What this trial is testingOmacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more Roswell Park Cancer Institute 2
Early research (Phase 1)Active Not RecruitingNCT04454658What this trial is testingSafety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With MyelofibrosisWho this might be right forMyelofibrosis (MF) AbbVie 21
Testing effectiveness (Phase 2)Ended earlyNCT00510289What this trial is testingSorafenib in Myelodysplastic SyndromeWho this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic Duke University 19
Testing effectiveness (Phase 2)Study completedNCT01527045What this trial is testingDonor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAggressive Non-Hodgkin LymphomaBlasts Under 5 Percent of Bone Marrow Nucleated CellsChronic Lymphocytic Leukemia+18 more Fred Hutchinson Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT00005805What this trial is testingSt. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+5 more Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01053494What this trial is testingMassage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more Wake Forest University Health Sciences 80
Not applicableStudy completedNCT00896129What this trial is testingMid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line TherapyWho this might be right forChronic Myeloid Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 448
Testing effectiveness (Phase 2)Ended earlyNCT00415857What this trial is testingProteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)Who this might be right forLeukemia M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00002502What this trial is testingCombination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01916785What this trial is testingOPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy)Who this might be right forChronic Myelogenous Leukemia, BCR/ABL Positive Versailles Hospital 289